Lark's A.I. for Diabetes Study Shows That Patients Significantly Reduce A1c

The diabetes epidemic is one of the most pervasive health crises in the U.S., and recently became its most costly. The overall demand for better healthcare services for the U.S. diabetic population far exceeds existing capabilities. In this paper we describe how a digital, infinitely scalable, standalone solution can drive population benefits among people with type 2 diabetes. Our analysis focuses on early results of the Lark Diabetes Care program and seeks to evaluate the potential impactLark's platform, leveraging Conversational Artificial Intelligence, has on improving A1c for those with type 2 diabetes (DM2).